Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_03860 |
| Species: | Mus musculus |
| Position : | chr5:98290964-98295647 |
| Year: | 2014 |
| Title: | Reorganization of enhancer patterns in transition from naive to primed pluripotency. |
| Genome Build: | mm10 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| PMID: | 24905168 |
| Cell Source: | Mouse Embryonic Stem Cell |
| Experiment Type: | Enhancer activity assay; TF-binding/chromatin assay; In vivo functional validation |
| High Throughput Method: | ChIP-seq; RNA-seq |
| Low Throughput Method: | ChIP-qPCR/ChIP; RT-qPCR/qPCR |
| Target gene : | Fgf5 |
| TF name : | Pou5f1 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| Pou5f1 | HIF-2-alpha transcription factor network | pid | 34 |
| Pou5f1 | POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | reactome | 13 |
| Pou5f1 | POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | reactome | 10 |
| Pou5f1 | Transcriptional regulation of pluripotent stem cells | reactome | 28 |
| Pou5f1 | Hs_Endoderm_Differentiation_WP2853_88152 | wikipathways | 62 |
| Pou5f1 | Hs_Wnt_Signaling_Pathway_and_Pluripotency_WP399_90291 | wikipathways | 12 |
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_03859 | chr5:98290964-98295647 | NA | NA | NA |